Skip to main content

BRIEF-Eiger says FDA orphan drug designation granted for pegylated interferon lambda in hepatitis delta virus infection

* Eiger announces FDA orphan drug designation granted for pegylated interferon lambda in hepatitis delta virus infection Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.